AnalystsMayank MamtaniMayank Mamtani's Stock Forecasts
AnalystsMayank Mamtani
Analyst Ranking
Top 1%
#28 out of 3474 analysts
Average Return
+106.66%
Win Rate
66%19 out of 29
Risk vs Reward
Poor
Good
Mayank Mamtani's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Novavax IncNVAX | +1,295.56% | $13.05 | $182.12 | 2020-03-27 - 2021-03-26 | Strong Buy |
Novavax IncNVAX | +946.95% | $19.83 | $207.61 | 2020-04-24 - 2021-04-23 | Strong Buy |
Fortress Biotech IncFBIO | +221.05% | $1.33 | $4.27 | 2020-03-13 - 2021-03-12 | Strong Buy |
Arrowhead Pharmaceuticals IncARWR | +176.37% | $26.32 | $72.74 | 2020-03-13 - 2021-03-12 | Strong Buy |
Novavax IncNVAX | +149.90% | $83.61 | $208.94 | 2020-06-29 - 2021-06-29 | Strong Buy |
Mayank Mamtani's Stock Coverage
| Name / Ticker | # of Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Vaxart IncVXRT | 1 | Hold | $9.00 | +34.73% | Downgrades | 4 months ago |
Altimmune IncALT | 1 | Strong Buy | $21.00 | +90.91% | Maintains | 4 months ago |
Cassava Sciences IncSAVA | 1 | Strong Buy | $111.00 | +148.82% | Maintains | 4 months ago |
Eloxx Pharmaceuticals IncELOX | 1 | Strong Buy | $5.00 | +273.13% | Initiates Coverage On | 5 months ago |
Intercept Pharmaceuticals IncICPT | 2 | Hold | $18.00 | +9.29% | Downgrades | 5 months ago |
Seelos Therapeutics IncSEEL | 1 | Strong Buy | $15.00 | +621.15% | Initiates Coverage On | 7 months ago |
Novavax IncNVAX | 6 | Strong Buy | $397.00 | +180.47% | Maintains | 8 months ago |
Tg Therapeutics IncTGTX | 2 | Strong Buy | $95.00 | +205.86% | Maintains | 9 months ago |
Arrowhead Pharmaceuticals IncARWR | 2 | Strong Buy | $106.00 | +64.37% | Maintains | 9 months ago |
Arcturus Therapeutics Holdings IncARCT | 2 | Hold | $77.00 | +69.12% | Downgrades | 9 months ago |
Acasti Pharma IncACST | 1 | Strong Buy | $2.00 | N/A | Upgrades | a year ago |
Galmed Pharmaceuticals LtdGLMD | 2 | Hold | $8.00 | N/A | Downgrades | a year ago |
Galectin Therapeutics IncGALT | 1 | Strong Buy | $4.00 | N/A | Maintains | 2 years ago |
IMV IncIMV | 1 | Hold | $3.00 | N/A | Downgrades | 2 years ago |
Liberty Media CorpFWONK | 1 | Strong Buy | $39.00 | N/A | Maintains | 2 years ago |
CymaBay Therapeutics IncCBAY | 1 | Hold | $1.50 | N/A | Maintains | 2 years ago |
Allena Pharmaceuticals IncALNA | 2 | Strong Buy | $4.00 | N/A | Maintains | 2 years ago |
X4 Pharmaceuticals IncXFOR | 1 | Strong Buy | $19.00 | N/A | Maintains | 2 years ago |
Medicinova IncMNOV | 1 | Strong Buy | $11.00 | N/A | Maintains | 2 years ago |
Genfit SAGNFT | 1 | Strong Buy | $34.00 | N/A | Maintains | 2 years ago |
Fortress Biotech IncFBIO | 2 | Strong Buy | $6.00 | N/A | Maintains | 2 years ago |
Spectrum Pharmaceuticals IncSPPI | 2 | Strong Buy | $8.00 | N/A | Maintains | 2 years ago |
Ngm Biopharmaceuticals IncNGM | 1 | Strong Buy | $30.00 | N/A | Maintains | 2 years ago |
Arqule IncARQL | 1 | Hold | $20.00 | N/A | Downgrades | 2 years ago |
©2021 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.